Literature DB >> 10411802

Assessment of response to treatment in vulvar vestibulitis syndrome by means of the vulvar algesiometer.

L J Eva1, W M Reid, A B MacLean, G D Morrison.   

Abstract

OBJECTIVE: A pilot study was undertaken to investigate the utility of the vulvar algesiometer in correlating symptom improvement with treatment response. STUDY
DESIGN: Women with a diagnosis of vulvar vestibulitis syndrome attending a specialist vulvar clinic were assessed with the vulvar algesiometer before and after treatment.
RESULTS: The conditions of 25 patients had improved to the point of discharge, and readings from before and after treatment were compared. There was a statistically significant difference in the vulvar algesiometer readings before and after treatment and this improvement was reflected in patient response. Nine patients had no response to treatment and also no significant improvement in vulvar algesiometer score.
CONCLUSION: The vulvar algesiometer provides an easy noninvasive means of assessing vestibular tenderness in vulvar vestibulitis syndrome that is well tolerated by the patients and provides a degree of biofeedback for them.

Entities:  

Mesh:

Year:  1999        PMID: 10411802     DOI: 10.1016/s0002-9378(99)70442-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Vulval vestibulitis.

Authors:  Pat Munday; Ann Buchan
Journal:  BMJ       Date:  2004-05-22

2.  Toward a better understanding of the relationship between vulvodynia and chronic stressors.

Authors:  Gloria Bachmann; Candace Brown; David C Foster
Journal:  J Womens Health (Larchmt)       Date:  2014-08       Impact factor: 2.681

3.  Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Ellen L Poleshuck; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2010-09       Impact factor: 7.661

4.  Does Degree of Vulvar Sensitivity Predict Vulvodynia Characteristics and Prognosis?

Authors:  Barbara D Reed; Melissa A Plegue; Siobán D Harlow; Hope K Haefner; Ananda Sen
Journal:  J Pain       Date:  2016-10-24       Impact factor: 5.820

5.  Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response.

Authors:  Candace S Brown; David C Foster; Jim Y Wan; Leslie A Rawlinson; Gloria A Bachmann
Journal:  Contemp Clin Trials       Date:  2013-06-29       Impact factor: 2.226

6.  The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

7.  Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women.

Authors:  David C Foster; Megan L Falsetta; Collynn F Woeller; Stephen J Pollock; Kunchang Song; Adrienne Bonham; Constantine G Haidaris; Chris J Stodgell; Susan P Messing; Michael Iadarola; Richard P Phipps
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.